Increased number of CD34+cells in nasal mucosa of allergic rhinitis patients: inhibition by a local corticosteroid
- 10 September 2004
- journal article
- clinical trial
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 35 (1) , 34-38
- https://doi.org/10.1111/j.1365-2222.2004.02038.x
Abstract
Background Eosinophils develop from CD34+ haematopoietic progenitor cells. Allergen exposure in susceptible individuals is known to induce a local eosinophilic inflammation, but the effect on progenitor cells is much less understood. Objective We aimed to evaluate how allergen exposure affects the number of tissue CD34+ cells and CD34+ eosinophils in allergic rhinitis (AR) patients and whether any such effect is influenced by local corticosteroid treatment. Also, we evaluated changes in the number of CXC receptor 4‐positive cells (CXCR4+), since the CXCR4 ligand (stromal cell‐derived factor‐1 (SDF‐1)) is a potent chemoattractant for haematopoietic progenitors. Methods In a double‐blind, randomized study, pollen‐sensitized AR patients were treated with a nasal corticosteroid fluticasone propionate (FP, 200 μg/day) or placebo throughout the pollen season. Nasal biopsies were taken before and during the season. CD34 and CXCR4 were stained using immunohistochemistry. Results The pollen season significantly increased the number of CD34+ cells, CD34+/CXCR4+ cells and CD34+ eosinophils in placebo‐treated patients, but not in FP‐treated patients. The mean pollen season‐induced increase in CD34+ cells, CD34+/CXCR4+ cells and CD34+ eosinophils in FP‐treated patients was lower compared with placebo‐treated patients. Conclusion A pollen season increases the number of CD34+ cells in nasal tissue accompanied by an increase in the number of CD34+/CXCR4+ haematopoietic progenitors and also the number of CD34+ eosinophils in subjects with AR. Treatment with a local corticosteroid provides protection against this pollen‐induced increase in tissue CD34+ cells and CD34+ eosinophils possibly via inhibition of allergen‐induced CXCR4‐mediated recruitment of CD34+ haematopoietic progenitors into airways and their further differentiation into eosinophils within the tissue.Keywords
This publication has 12 references indexed in Scilit:
- Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 2002
- Hematopoietic Stem Cells Are Uniquely Selective in Their Migratory Response to ChemokinesThe Journal of Experimental Medicine, 2002
- The Effects of Inhaled Budesonide on Circulating Eosinophil Progenitors and Their Expression of Cytokines after Allergen Challenge in Subjects with Atopic AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2000
- An Inhaled Corticosteroid, Budesonide, Reduces Baseline but Not Allergen-induced Increases in Bone Marrow Inflammatory Cell Progenitors in Asthmatic SubjectsAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Immunolocalization of CD34 in Nasal PolyposisAmerican Journal of Respiratory Cell and Molecular Biology, 1999
- Allergen Challenge Increases Cell Traffic between Bone Marrow and LungAmerican Journal of Respiratory Cell and Molecular Biology, 1998
- Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar developmentNature, 1998
- The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34+ Progenitors to Peripheral BloodThe Journal of Experimental Medicine, 1997
- Allergen-induced changes in bone marrow progenitors and airway responsiveness in dogs and the effect of inhaled budesonide on these parameters.American Journal of Respiratory Cell and Molecular Biology, 1994
- Expression of the CD34 gene in vascular endothelial cellsBlood, 1990